-
Neoadjuvant immune checkpoint blockade in women with mismatch repair...
Neoadjuvant immune checkpoint blockade (ICB) has shown unprecedented activity in mismatch repair deficient (MMRd) colorectal cancers, but its effectiveness in MMRd endometrial...